Sign in

    NeueHealth (NEUE)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970 (Before Market Open)
    Pre-Earnings Price$6.84Last close (Aug 6, 2025)
    Post-Earnings Price$6.83Open (Aug 7, 2025)
    Price Change
    $-0.01(-0.15%)
    MetricYoY ChangeReason

    ACO REACH Revenue (Q1 2024)

    -28.4% / -$68.0 million

    The revenue drop was driven by a reduction of approximately 23,000 beneficiaries aligned to REACH ACOs, reflecting a shift in the underlying membership base and impacting overall revenue streams.

    Total Revenue (Q1 2024)

    Decreased from $300.6M to $245.1M

    Overall revenue declined primarily due to lower ACO REACH performance and moderately lower volume in the NeueCare segment, despite a 24.1% increase in capitated revenue that was partly offset by a decline in service revenue.

    ACO REACH Revenue (Q1 2025)

    Decrease of $47.8 million

    A further reduction in beneficiaries (approximately 13,000) and a strategic shift in membership mix away from REACH ACOs contributed significantly to the decline in ACO REACH revenue compared to the prior period.

    Capitated Revenue (Q1 2025)

    +31.8% / +$19.5 million

    Increased membership through third-party payor contracts led to a strong growth in capitated revenue, partially mitigating the overall revenue decline from other segments.

    Service Revenue (Q1 2025)

    Decreased by $1.8 million

    The decline in service revenue was primarily driven by the sale of AMD in November 2024, reflecting a one-time adjustment impacting the revenue mix in the subsequent period.

    Research analysts covering NeueHealth.